Down syndrome (DS) is associated with an increased risk of
and Franco Calabi (Institute of Child Health, London, UK). Figure 1 shows a map of chromosome 21, indicating the relative positions of the locus-specific probes used in this study. Introduction
Individuals with trisomy 21, Down syndrome (DS), have an
Fluorescence in situ hybridization (FISH) increased risk of developing leukemia, 1 but the basis for this association is uncertain. Recognition of non-random chromo-FISH was carried out on metaphases prepared from the same some abnormalities has been instrumental in identifying genes samples used for conventional cytogenetic analysis. Probes involved in the development of several different types of leuwere hybridized in pairs (one biotin-labeled, the other digoxikemia but up to now no acquired chromosome abnormalities genin labeled) and for each patient a hybridization experiment have been found to be particularly associated with leukemias using the complete panel of probes was processed at the same arising in DS patients. 2, 3 time. Control metaphases from a normal individual were also In the course of conventional G-band analysis of a series of hybridized as an internal control for hybridization efficiency. DS patients with leukemia, we noticed that in two cases one
The whole chromosome 21-specific paint, alpha-satellite copy of chromosome 21 in the leukemic cells appeared shorter in the long-arm. Fluorescence in situ hybridization (FISH) with a whole chromosome paint for 21 failed to demonstrate evidence of translocation, but using a panel of locusspecific probes we have found interstitial deletions in both cases and in the malignant cells from three additional cases in which no deletion was suspected. This finding suggests an important role for gene(s) on chromosome 21 in the genesis or progression of the leukemic state in patients with DS and leukemia.
Materials and methods

Patients
Five children with DS and leukemia, one with acute lymphoblastic leukemia (ALL) and four with acute myeloid leukemia (AML), were selected for this study on the basis of availability of sufficient good-quality metaphases (see below). Bone marrow chromosomes obtained at the time of diagnosis of leukemia were processed by standard methods. Karyotypes are described according to ISCN (1995) .
probe and locus-specific probes for D21S65, D21S55, D21S19, D21S1219 and D21S1220 were prepared according to the manufacturer's instructions. C4C10 was nick-translated using Biotin-14 dATP (Gibco BRL, Renfrewshire, UK). Slides were denatured at 70°C in 70% formamide, 2 × SSC for 2 min and dehydrated in an ethanol series. Probes were then placed on the slides, sealed and incubated overnight at 37°C.
All post-hybridization washes for the whole chromosome paint, alpha-satellite probe and commercial locus-specific probes were performed according to procedures recommended by the manufacturers. C4C10 was washed at 43°C for 15 min in 60% formamide, 2 × SSC and for a further 15 min in 2 × SSC. Signal detection with fluorescein avidin-and biotinylated anti-avidin-labeled antibodies (Vector, Peterborough, UK) and anti-digoxigenin-rhodamine conjugate (Boehringer, Lewes, UK) were performed according to protocols recommended by the manufacturers. Cells were viewed using a Zeiss Axioskop microscope equipped with a CCD camera (Photometrics, Tucson, AZ, USA) connected to a Macintosh Quadra Computer. Image analysis was effected using a SmartCapture software (Digital Scientific, Cambridge, UK).
Analysis
Only metaphases showing clear signals and no/very low background were assessed in order to eradicate artifactual misinterpretation. In each case and for each probe, 10 normal and 25 leukemic metaphases were evaluated by visual assessment and measurement of signal intensity/size using the Graph polygon program in SmartCapture software. In all cases, some probes were found to be partially deleted (ie had reduced signal intensities). In each instance, the ratios of reduced/nonreduced signals remained constant to within a 10% value for each patient, although the sizes of the partial deletions varied from case to case. Examples of graph polygons illustrating normal, reduced and absent signals from case 2 are shown in Figure 2 .
Southern blot analysis
Southern blot hybridization was carried out using a composite 21A/21b probe, identifying both the 11 kb BamHI fragment harbouring AML1 exon 5 and the 20 kb BamHI fragment harbouring AML1 exon 6 as previously described. 6 
Results
Conventional cytogenetic analysis
Figure 2
Ratio profiles generated using the Graph polygon SmartClinical and cytogenetic results are shown in analysis.
(digoxigenin-labeled) showing an absent signal for C4C10.
probes we found long-arm interstitial deletions of one chro-FISH mosome 21 in the leukemic cells from each patient. In patients 2 and 3, the deletions were detectable in some GUsing a whole chromosome paint, we found no evidence for translocations involving chromosome 21 in the normal or leubanded metaphases found in their leukemic clones. In no instance was a deletion found in the non-leukemic cells. The kemic cells from any case. However, using the locus-specific results are shown in Figure 3 and representative examples in arising in DS patients with those in non-DS individuals reveals Figures 4-7. a number of differences, including age distribution and The breakpoints in the four patients with AML (cases [2] [3] [4] [5] phenotypes, but there are no particular patterns of acquired occurred in the interval defined by D21S65 and D21S55, with chromosome abnormalities which set the DS patients apart.
2,3
the smallest deletion found in patient 5, involving only locus The neonatal disorder of transient abnormal myelopoiesis D21S55. In the patient with ALL (case 1) two deletions were (TAM), is found almost exclusively in DS or DS mosaics, and found, breakage having occurred in two regions of the long in these cases always involves cells with trisomy 21. TAM usuarm, the more proximal involving C4C10 and the more distal ally resolves spontaneously but approximately 25% of patients region being between D21S19 and the telomere.
may present up to 3 years later with AML. 3 The increased risk of hematological malignancy and the involvement of trisomy 21 cells in DS mosaics with TAM has suggested that trisomy Southern blot analysis 21 is a predisposing factor and that other events may be required before leukemia develops. 1 In order to rule out an involvement of the AML1 locus at Our finding of chromosome 21 long-arm deletions restric21q22, Southern blot analysis was carried out on BamHI ted to the malignant cells of five children with DS, is strong digested DNA from the two patients (cases 3 and 5) from evidence for a gene(s) on the chromosome being important in whom presentation DNA samples were available. No the development of their leukemias. Patient 2 in the present rearrangement was found. study had TAM in the neonatal period but unfortunately no sample was available for chromosome analysis at that time. Loss of heterozygosity, as a result of chromosome loss or Discussion deletion, is considered a hallmark of the involvement of a gene whose loss of function is important in the initiation or It has been recognized for many years that individuals with progression of malignancy. 7 In this regard, the case of ALL Down syndrome have an increased risk of developing leukearising in a child with DS described in detail by Rogan et al 8 mias, but not other malignancies. 1 Comparison of leukemias is of interest. Constitutionally, the patient had one paternal and two maternal copies of chromosome 21, with maternal isodisomy for part of the long-arm. In the leukemic clone, the paternal chromosome 21 was lost, reducing to homozygosity all loci distal to D21S262, which maps close to D21S65.
9
Such a rearrangement could expose a recessive mutation or gene deletion. Partial deletion of one copy of chromosome 21 in trisomic leukemia cells, such as we have found, could result in a similar situation, if there was homozygosity for a tumorigenic mutation or gene deletion on the remaining chromosomes. Lack of material prevented us from determining the parental origins of the chromosomes in any of our cases, but such an analysis will be a priority in our future studies. The FISH probes we have used so far were chosen to include the region containing genes responsible for many of the phenotypic features of DS 10 as well as the AML1 gene which is known to be involved in translocations found in many myeloid and lymphoid leukemias.
11- 15 The AML1 locus
Figure 3
Deletion map for 21q loci in leukemic cells from five patients with Down syndrome and leukemia.
was included in the deleted segments in cases 1-4 and appeared to be intact in case 5. Southern blot studies were close to D21S55 9 were not tested. No rearrangements of AML1, ERG or ETS2 were found in the case of AML with penonly possible in cases 3 and 5 and no rearrangements were found. tasomy 21 studied by Rogan et al. 8 The deletions we have found were variable in extent, and Two other possible candidate genes, ERG, which is involved in 16;21 translocations 16 and ETS2, which both map in future studies we hope to define the deleted segment more
